Development Level

Tbio 18 | 10,625
Tchem 4 | 1,890
Tdark 4 | 7,003

IMPC Phenotype

increased exploration in new e... 1 | 56

Disease

ovarian cancer 12 | 8,491
lung adenocarcinoma 11 | 2,714
intraductal papillary-mucinous neoplasm (IPMN) 10 | 3,289
intraductal papillary-mucinous adenoma (IPMA) 9 | 2,956
osteosarcoma 9 | 7,933
Breast cancer 8 | 3,098
Cancer 8 | 2,346
intraductal papillary-mucinous carcinoma (IPMC) 8 | 2,988
pancreatic cancer 8 | 2,300
psoriasis 8 | 6,685
lung cancer 7 | 4,473
ulcerative colitis 7 | 2,087
Carcinoma 6 | 2,147
cystic fibrosis 6 | 1,670
medulloblastoma, large-cell 6 | 6,234
nasopharyngeal carcinoma 6 | 1,056
Adenoma 4 | 165
Biliary papillomatosis 4 | 4
Otitis media 4 | 32
active Crohn's disease 4 | 918
breast carcinoma 4 | 1,614
diabetes mellitus 4 | 1,663
interstitial cystitis 4 | 2,299
lung carcinoma 4 | 2,844
non-small cell lung cancer 4 | 2,798
pituitary cancer 4 | 1,972
Asthma 3 | 349
Gastritis 3 | 44
esophageal adenocarcinoma 3 | 737
glioblastoma 3 | 5,572
group 4 medulloblastoma 3 | 1,875
interstitial lung disease 3 | 292
invasive ductal carcinoma 3 | 2,950
pancreatic ductal adenocarcinoma liver metastasis 3 | 1,795
posterior fossa group A ependymoma 3 | 1,511
spina bifida 3 | 1,064
Amyotrophic Lateral Sclerosis 2 | 432
Atopic dermatitis 2 | 944
Bronchitis 2 | 44
Chronic obstructive pulmonary disease 2 | 147
Common cold 2 | 63
Dry eye syndrome 2 | 14
Endometrial cancer 2 | 32
Gastrointestinal system disease 2 | 50
Kidney cancer 2 | 121
Malignant neoplasm of esophagus 2 | 18
Multiple myeloma 2 | 1,327
Pneumonia 2 | 133
Sinusitis 2 | 30
Stomach Neoplasms 2 | 282
Systemic scleroderma 2 | 66
active ulcerative colitis 2 | 477
adult high grade glioma 2 | 2,148
colon cancer 2 | 1,475
ductal carcinoma in situ 2 | 1,745
group 3 medulloblastoma 2 | 2,254
malignant mesothelioma 2 | 3,163
non primary Sjogren syndrome sicca 2 | 840
periodontitis 2 | 269
primary Sjogren syndrome 2 | 788
primary pancreatic ductal adenocarcinoma 2 | 1,271
urothelial carcinoma 2 | 318
Adenocarcinoma 1 | 115
Adenoid Cystic Carcinoma 1 | 99
Allergic rhinitis 1 | 92
Alzheimer's disease 1 | 644
Colitis 1 | 46
Crohn Disease 1 | 97
DOID:2627 1 | 14
Dental caries 1 | 67
Dermatitis, Allergic Contact 1 | 66
Diabetes Mellitus, Non-Insulin-Dependent 1 | 161
Drug-Induced Liver Injury 1 | 118
Epilepsy 1 | 346
IGA Glomerulonephritis 1 | 454
Inflammatory Bowel Diseases 1 | 87
Influenza 1 | 142
Liver cancer 1 | 31
Melanoma 1 | 261
Mesothelioma 1 | 40
Multiple Sclerosis 1 | 498
Primary ciliary dyskinesia 1 | 75
Proteinuria 1 | 63
Relapsing fever 1 | 16
Renal Cell Carcinoma 1 | 199
Salivary Gland Neoplasms 1 | 45
Spontaneous abortion 1 | 108
Thyrotoxicosis 1 | 38
Type 2 diabetes mellitus 1 | 192
Vitiligo 1 | 71
West Syndrome 1 | 24
atypical teratoid/rhabdoid tumor 1 | 1,095
chronic rhinosinusitis 1 | 512
cystic fibrosis and chronic rhinosinusitis 1 | 213
facioscapulohumeral dystrophy 1 | 286
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
non-small cell lung carcinoma 1 | 413
ovarian neoplasm 1 | 97
sarcoidosis 1 | 368
tuberculosis and treatment for 6 months 1 | 686

Tissue

Cardiovascular System 24 | 17,957
Digestive Tract 24 | 18,472
Liver and Pancreas 24 | 18,135
Male tissues 24 | 17,968
Respiratory system 24 | 17,483
Urinary Tract 24 | 18,443
Blood and immune system 23 | 17,994
Endocrine System 23 | 18,511
Female tissues 23 | 18,646
Nervous System 23 | 18,560
Skin and soft tissues 23 | 18,114

Target Family

Non-IDG 18 | 11,969
Enzyme 8 | 4,146

Reactome Pathway

Termination of O-glycan biosyn... 26 | 26
Signal Transduction 2,515 | 2,515
Immune System 2,183 | 2,183
Metabolism 2,131 | 2,131
Gene Expression 1,754 | 1,754
Metabolism of proteins 1,544 | 1,544
Innate Immune System 1,375 | 1,375
Signaling by GPCR 1,329 | 1,329
Developmental Biology 1,028 | 1,028
GPCR downstream signaling 1,015 | 1,015
Post-translational protein mod... 1,004 | 1,004
Adaptive Immune System 938 | 938
Disease 855 | 855
Generic Transcription Pathway 852 | 852
Cytokine Signaling in Immune s... 803 | 803
Metabolism of lipids and lipop... 797 | 797
Vesicle-mediated transport 705 | 705
Hemostasis 669 | 669
Transmembrane transport of sma... 668 | 668
Membrane Trafficking 608 | 608
Cell Cycle 572 | 572
Neutrophil degranulation 542 | 542
Axon guidance 541 | 541
Signaling by Interleukins 500 | 500
Cell Cycle, Mitotic 470 | 470
Signalling by NGF 467 | 467
GPCR ligand binding 456 | 456
Gastrin-CREB signalling pathwa... 435 | 435
Class I MHC mediated antigen p... 430 | 430
Olfactory Signaling Pathway 430 | 430
Fc epsilon receptor (FCERI) si... 423 | 423
Cellular responses to stress 415 | 415
DAP12 interactions 409 | 409
Infectious disease 391 | 391
NGF signalling via TRKA from t... 378 | 378
Signaling by Rho GTPases 378 | 378
Signaling by PDGF 367 | 367
Diseases of signal transductio... 359 | 359
Transcriptional Regulation by ... 356 | 356
Signaling by EGFR 355 | 355
Metabolism of amino acids and ... 353 | 353
DAP12 signaling 346 | 346
Downstream signal transduction 343 | 343
Neuronal System 343 | 343
Organelle biogenesis and maint... 334 | 334
Signaling by VEGF 329 | 329
Signaling by SCF-KIT 327 | 327
Class A/1 (Rhodopsin-like rece... 322 | 322
VEGFA-VEGFR2 Pathway 321 | 321
FCERI mediated MAPK activation 316 | 316
Signaling by Insulin receptor 312 | 312
Antigen processing: Ubiquitina... 301 | 301
Extracellular matrix organizat... 292 | 292
Signaling by Type 1 Insulin-li... 290 | 290
Signaling by Wnt 290 | 290
IGF1R signaling cascade 289 | 289
IRS-related events triggered b... 289 | 289
Insulin receptor signalling ca... 288 | 288
Metabolism of carbohydrates 288 | 288
DNA Repair 286 | 286
IRS-mediated signalling 285 | 285
MAPK family signaling cascades 283 | 283
Asparagine N-linked glycosylat... 282 | 282
Signaling by the B Cell Recept... 282 | 282
SLC-mediated transmembrane tra... 280 | 280
Deubiquitination 277 | 277
Interferon Signaling 275 | 275
Platelet activation, signaling... 274 | 274
NCAM signaling for neurite out... 268 | 268
M Phase 266 | 266
Interleukin-3, 5 and GM-CSF si... 262 | 262
RET signaling 261 | 261
Signalling to ERKs 254 | 254
Interleukin-2 signaling 253 | 253
Immunoregulatory interactions ... 252 | 252
RHO GTPase Effectors 249 | 249
VEGFR2 mediated cell prolifera... 249 | 249
Signalling to RAS 247 | 247
Interleukin receptor SHC signa... 246 | 246
G alpha (i) signalling events 245 | 245
Fatty acid, triacylglycerol, a... 244 | 244
Signaling by Leptin 244 | 244
Prolonged ERK activation event... 243 | 243
MAPK1/MAPK3 signaling 242 | 242
Frs2-mediated activation 241 | 241
HIV Infection 241 | 241
ARMS-mediated activation 240 | 240
Signalling to p38 via RIT and ... 240 | 240
Chromatin modifying enzymes 237 | 237
Chromatin organization 237 | 237
GRB2 events in EGFR signaling 236 | 236
RAF/MAP kinase cascade 236 | 236
SHC1 events in EGFR signaling 236 | 236
SOS-mediated signalling 236 | 236
Processing of Capped Intron-Co... 235 | 235
Biological oxidations 215 | 215
Keratinization 213 | 213
Transmission across Chemical S... 210 | 210
rRNA processing 209 | 209
Ion channel transport 204 | 204
Phospholipid metabolism 202 | 202

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Mucin-5AC MUC5AC Tchem Non-IDG -3.19883 932.0 284
Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 ST6GALNAC3 Tbio Enzyme -0.87609 6.75 20
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 ST3GAL1 Tchem Enzyme -1.78287 60.2 45
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4 ST3GAL4 Tbio Enzyme -2.17614 144.0 79
CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase ST3GAL3 Tbio Enzyme -1.73984 54.9 95
Mucin-17 MUC17 Tbio Non-IDG -1.17485 19.0 23
Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase ST6GALNAC4 Tdark Enzyme -0.79334 4.99 63
Mucin-13 MUC13 Tbio Non-IDG -1.84681 69.6 173
Mucin-1 MUC1 Tbio Non-IDG -3.52177 3532.0 1851
Mucin-3B MUC3B Tdark Non-IDG -0.31564 3.54 0